Daily Archives: January 21, 2021

COVID-19: FDA advisory committee needed before more EUAs for monoclonals

By on .

Press release claims benefit in nursing home COVID prevention study By Daniel R. Lucey MD, MPH, FIDSA  In a press release today Lilly reported that its “neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial, reducing risk by up to 80% for residents”.  The release states that the intravenous dose used […]